Globus Medical, Inc. logo GMED - Globus Medical, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 27
HOLD 8
SELL 1
STRONG
SELL 0
| PRICE TARGET: $110.29 DETAILS
HIGH: $117.00
LOW: $100.00
MEDIAN: $112.00
CONSENSUS: $110.29
UPSIDE: 30.04%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 85% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Fair Value Moderate
Trading 19.9% below fair value
Current Price $84.81
Bear Case $75.52 11.0% downside ($75.52 - $84.81) / $84.81 = -11.0% 7% stage 1 growth, 11% discount
Fair Value $105.91 24.9% upside ($105.91 - $84.81) / $84.81 = 24.9% 12% stage 1 growth, 11% discount
Bull Case $137.15 61.7% upside ($137.15 - $84.81) / $84.81 = 61.7% 15% stage 1 growth, 11% discount

Adjust Assumptions

11.8%
11.0%
3.0%

Key Value Driver

FCF growth rate (12% base case)

Terminal Value % of EV 40%
Implied Market Multiple 19.9x

Plain-Language Summary

Our base-case estimate uses a two-stage discounted cash flow model based on free cash flow. We then blend that result with the average analyst price target of $110.29 from 36 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $105.91 per share.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions